proadifen has been researched along with Goldblatt Syndrome in 2 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The lipid in the RVE gave the same dose-response as extracted Med I." | 1.28 | Secretion of medullipin I by isolated kidneys perfused under elevated pressure. ( Brooks, B; Brown, P; Byers, LW; Muirhead, EE; Pitcock, JA, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muirhead, EE | 1 |
| Brooks, B | 2 |
| Byers, LW | 2 |
| Brown, P | 2 |
| Pitcock, JA | 2 |
| Muirhead, E | 1 |
| Capdevila, J | 1 |
| Dowell, R | 1 |
2 other studies available for proadifen and Goldblatt Syndrome
| Article | Year |
|---|---|
Secretion of medullipin I by isolated kidneys perfused under elevated pressure.
Topics: Angiotensin II; Animals; Blood Pressure; Hypertension, Renovascular; In Vitro Techniques; Kidney; Le | 1991 |
Effect of cytochrome P-450 induction and inhibition on the antihypertensive function of the kidney.
Topics: Animals; Blood Pressure; Clofibric Acid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 1987 |